Plus Therapeutics, Inc.
PSTV
$0.2025
-$0.1061-34.38%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -433.61% | -2.44% | 10.72% | -98.38% | 32.13% |
| Total Depreciation and Amortization | -5.81% | 58.46% | 23.40% | 7.37% | -1.90% |
| Total Amortization of Deferred Charges | -- | -100.00% | -100.00% | -92.45% | -75.76% |
| Total Other Non-Cash Items | 6,934.27% | -16.28% | -495.52% | -1,048.65% | 4.09% |
| Change in Net Operating Assets | 10.18% | 50.57% | -142.39% | 255.40% | -15.76% |
| Cash from Operations | -36.76% | 35.62% | -53.40% | 58.60% | 22.10% |
| Capital Expenditure | 92.50% | 73.81% | -40.00% | -636.36% | 58.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,189.81% | -- | -- | -- | -- |
| Cash from Investing | 1,077.47% | 252.38% | 10.00% | -34,463.64% | -275.26% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,640.05% | 100.00% | 100.00% | -794.03% | 0.00% |
| Issuance of Common Stock | -- | -100.00% | -100.00% | 433.02% | -- |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,698.58% | 100.00% | -100.00% | 624.56% | -257.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 273.20% | 53.22% | -3,423.42% | 210.01% | -4.74% |